BATON ROUGE, La., May 25, 2017 -- Amedisys Inc. (NASDAQ:AMED), one of the nation’s leading home health care, hospice and personal care companies, has received an average rating of 4.03 Stars – out of a possible 5 – for Quality of Patient Care across all of its home health centers from the Centers for Medicare & Medicaid Services (CMS). That figure represents a 15% increase from a year ago and above the industry average. Three-fourths of its home health centers (75%) achieved a rating of 4 Stars or better, compared to thirty percent (30%) last year.
“No metric better demonstrates our determination to deliver outstanding clinical results than ratings in home health from the all-important CMS Star program,” stated President and Chief Executive Officer Paul Kusserow. “And we’re making tremendous strides. We’ve now seen improvement for six straight quarters, and we’re on track for every one of the 330 home health care centers we operate in 34 states to achieve a quality Star rating of 4 or higher by the end of this year.”
Indeed, fifty-three of Amedisys’ home health care centers rated 4.5 Stars, with five attaining 5 Stars. Patient Satisfaction Star ratings have risen to 3.8, also above the industry average.
“Our care centers rank among the top in the nation for delivering quality patient care,” stated Chief Clinical Officer Susan Sender. “In fact, our July preview shows our quality of patient care Star ratings averaging 4.13, with 82% of our home health care centers at 4 Stars or higher. This is a direct result of our commitment to clinical distinction and investing in our people to provide the highest quality of care to our patients.”
According to CMS, its Home Health Compare website is designed to be a key tool for consumers to use for choosing a home health provider – an “easy-to-access, convenient source of authoritative information on provider quality.” In 2015, CMS added to its reporting system a one-to-five Star rating, to “summarize” 24 measures of provider performance such as “timely initiation of care” and “improvement in ambulation.”
About Amedisys
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,200 hospitals and 61,900 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 16,000 employees, in 421 care centers in 34 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 385,000 patients in need every year. For more information about the Company, please visit: www.amedisys.com.
Contact: Kendra Kimmons Managing Director of Communications 225-299-3708 [email protected]


Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 



